← Back to Search
Fractional Flow Reserve-guided Percutaneous Coronary Intervention: Standing The Test Of Time
F. Zimmermann, L. X. V. Nunen
Published 2016 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Percutaneous coronary intervention (PCI) improves symptoms and prognosis in ischemia-inducing, functionally signifi cant, coronary lesions. Use of fractional fl ow reserve allows physicians to investigate the ischemia-inducing potential of a specifi c lesion and can be used to guide coronary revascularization, especially in multivessel coronary artery disease. Fractional fl ow reserve-guided PCI has been extensively investigated. Results show that deferral of stenting in non-signifi cant lesions is safe, whereas deferral of stenting in functionally signifi cant lesions worsens outcome. FFR-guided PCI improves outcome in multivessel disease over angiography-guided PCI. Until recently, there was little known about the long-term outcome of FFR-guided revascularization and its validity in acute coronary syndromes. This review aims to address the new evidence regarding long-term appropriateness of FFR-guided PCI, the need for hyperemia to evaluate functional severity, and the use of FFR in acute coronary syndromes.
This paper references
F. Sones (1962)
Instantaneous Flow Response and Regional Distribution During Coronary Hyperemia as Measures of Coronary Flow Reserve
K. Gould (1974)
Discrepancies Between Cineangiographic and Postmortem Findings in Patients with Coronary Artery Disease and Recent Myocardial Revascularization
C. Grondin (1974)
Coronary angiogram interpretation. Interobserver variability.
J. E. Galbraith (1978)
Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty.
A. Gruentzig (1979)
Effects of adenosine on human coronary arterial circulation.
R. Wilson (1990)
Experimental Basis of Determining Maximum Coronary, Myocardial, and Collateral Blood Flow by Pressure Measurements for Assessing Functional Stenosis Severity Before and After Percutaneous Transluminal Coronary Angioplasty
N. Pijls (1993)
Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography.
B. de Bruyne (1994)
Coronary fl ow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation 1994;89:1013–22
B De Bruyne (1994)
Coronary fl ow reserve calculated from pressure measurements in humans . Validation with positron emission tomography
B DeBruyne (1994)
Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease.
E. Topol (1995)
Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses.
N. Pijls (1996)
Simultaneous coronary pressure and flow velocity measurements in humans. Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve.
B. de Bruyne (1996)
Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction.
R. Hachamovitch (1998)
Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making
E. Di Segni (2001)
Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis A Randomized Trial
G. J. W. Bech (2001)
Incremental doses of intracoro - nary adenosine for the assessment of coronary velocity reserve for clinical decision making
E DiSegni (2001)
Intracoronary and Intravenous Adenosine 5′-Triphosphate, Adenosine, Papaverine, and Contrast Medium to Assess Fractional Flow Reserve in Humans
B. de Bruyne (2003)
Intracoronary and intravenous adenosine 5 -triphosphate, adenosine, papaverine, and contrast medium to assess fractional fl ow reserve in humans. Circulation 2003;107:1877–83
B De Bruyne (2003)
Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study.
N. Pijls (2007)
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
L. Shaw (2008)
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
B. Gersh (2009)
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.
Pim A. L. Tonino (2009)
Frequency of Stress Testing to Document Ischemia Prior to Elective Percutaneous Coronary Intervention
B. Gersh (2009)
Update on FFR-Guided PCI 232 et al. Fractional fl ow reserve versus angiography for guiding percutaneous coronary intervention
PA Tonino (2009)
Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction.
A. Ntalianis (2010)
Clinical utility of regadenoson for assessing fractional flow reserve.
Pradeep K. Nair (2011)
Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation
B. Gersh (2011)
Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study.
S. Sen (2012)
VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in EverydaY Practice): a multicenter study in consecutive patients.
C. Berry (2013)
Functional assessment of coronary stenoses: can we live without it?
N. Pijls (2013)
Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve.
P. Arumugham (2013)
Fractional flow reserve-guided PCI for stable coronary artery disease.
B. de Bruyne (2014)
Use of regadenoson for measurement of fractional flow reserve
Aditya Prasad (2014)
Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study.
Allen Jeremias (2014)
Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes.
N. Johnson (2014)
Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?: The RIPCORD Study
N. Curzen (2014)
Fractional fl ow reserveguided PCI for stable coronary artery disease
B De Bruyne (2014)
Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement.
L. V. van Nunen (2015)
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial
T. Engstrom (2015)
Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS–NSTEMI randomized trial
J. Layland (2015)
Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial
L. V. Nunen (2015)
Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory.
J. Stolker (2015)
Intracoronary Adenosine: Dose-Response Relationship With Hyperemia.
J. Adjedj (2015)
Prospective Assessment of the Diagnostic Accuracy of Instantaneous Wave-Free Ratio to Assess Coronary Stenosis Relevance: Results of ADVISE II International, Multicenter Study (ADenosine Vasodilator Independent Stenosis Evaluation II).
J. Escaned (2015)
Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease.
F. Zimmermann (2015)
Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial.
F. Zimmermann (2015)
Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional fl ow reserve measurement. EuroIntervention 2015;22:905–13
LX van Nunen (2015)
The CONTRAST study: can contrast injection better approximate FFR compared to pure resting physiology? Presented at EuroPCR
NP Johnson (2015)
Invasive Assessment of the Coronary Microcirculation.
W. Fearon (2016)
This paper is referenced by
European survey on acute coronary syndrome diagnosis and revascularisation treatment: Assessing differences in reported clinical practice with a focus on strategies for specific patient cases
A. Peultier (2020)
Physiology-based treatment in stable angina and acute myocardial infarction
V. Nunen (2016)